Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005242
Filing Date
2024-11-14
Accepted
2024-11-14 16:26:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 armistice-prtg093024a1.htm SC 13G/A 89016
  Complete submission text file 0001172661-24-005242.txt   90815
Mailing Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110
Business Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110 416-737-7600
PORTAGE BIOTECH INC. (Subject) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-81765 | Film No.: 241462938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A